0. DOCID:30701 SCORE: 0.00439186965148416
DOCNO: 16050939
OWNER: NLM
STATUS: In-Process
AUTHOR: Susan G Lakoski SG
AUTHOR: David M Herrington DM
AFFILIATION: Department of Internal Medicine/Cardiology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Diabetes, obesity & metabolism.
COUNTRY: England
TITLE: Effects of oestrogen receptor-active compounds on lipid metabolism.
PUBDATE: 20050901
Selective estrogen receptor modulators (SERMs) have been used successfully in the treatment of breast cancer and osteoporosis while Tibolone has been used extensively in Europe for the treatment of menopausal symptoms. Limited data is available on the effect of these agents on the cardiovascular system. Traditional and novel lipid markers are valuable in determining patients at increased cardiovascular risk. The purpose of this article is to discuss the mechanism of action of Tamoxifen, Raloxifene and Tibolone and their effects on lipid metabolism.

1. DOCID:30601 SCORE: 0.00380951243867117
DOCNO: 15753432
OWNER: NLM
STATUS: In-Process
AUTHOR: C M Roe CM
AUTHOR: M I Behrens MI
AUTHOR: C Xiong C
AUTHOR: J P Miller JP
AUTHOR: J C Morris JC
AFFILIATION: Division of Biostatistics, Washington University School of Medicine, 660 South Euclid Avenue, Box 8067, St. Louis, MO 63110, USA. cathyr@wubios.wustl.edu
PUBTYPE: Journal Article
JOURNALTITLE: Neurology.
COUNTRY: United States
TITLE: Alzheimer disease and cancer.
PUBDATE: 20050301
Cross-sectional studies raise the possibility of protective relationships between, or a common mechanism underlying, the development of dementia of the Alzheimer type (DAT) and cancer. Using a prospective longitudinal design, the authors found that the risk of developing cancer is less among participants with DAT vs nondemented participants (p < 0.001) and that the risk of developing DAT may be less for participants with a history of cancer (p = 0.060).

2. DOCID:31533 SCORE: 0.00363629843150245
DOCNO: 14755362
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Surgery, Plastic
QUALIFIER: complications
QUALIFIER: pathology
QUALIFIER: surgery
AUTHOR: M Wollny M
AUTHOR: P Schmidt-Rhode P
AFFILIATION: Frauenklinik Barmbek-Finkenau, Hamburg. Maximilian.Wollny@t-online.de
PUBTYPE: Journal Article
JOURNALTITLE: Zentralblatt für Gynäkologie.
COUNTRY: Germany
TITLE: [Plastic surgery of defects of the thoracic wall]
PUBDATE: 20031201
Defects of the thoracic wall are mostly due to a malignant disease of the mammary gland. Radiotherapy is one of the essential methods of treating cancer of the breast in addition to primary surgery. If, after surgery, healing occurs by secondary intention or if there is a local recurrence or tumour formation in the thoracic wall due to irradiation, the body's reserves of soft parts are often exhausted and the adjacent tissue has been additionally damaged by the irradiation. General principles of treatment in the management of such problems are presented by means of several case reports.

3. DOCID:29300 SCORE: 0.00336887184239295
DOCNO: 14750313
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Nurse's Role
DESCRIPTOR: Oncologic Nursing
QUALIFIER: nursing
AUTHOR: Kumi Endo K
AFFILIATION: Dept. of Nursing, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-machi, Suntou-gun, Shizuoka 411-8777, Japan.
PUBTYPE: Journal Article
JOURNALTITLE: Gan to kagaku ryoho. Cancer & chemotherapy.
COUNTRY: Japan
TITLE: [Role of oncologic nurses in cancer chemotherapy]
PUBDATE: 20040101
The field of cancer chemotherapy requires specialized knowledge and skills, and nurses working in this field undergo specialized training. Oncologic nurses have a large role in cancer chemotherapy and demonstrate superior practical ability while also serving as counselors to patients and as promoters and coordinators of team-based medical care. They also work to carry out education and research on nursing in the field of cancer chemotherapy.

4. DOCID:30146 SCORE: 0.00326613042647226
DOCNO: 16115232
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: R J Kurman RJ
AUTHOR: J D Seidman JD
AUTHOR: I-M Shih IM
AFFILIATION: Department of Pathology, Washington Hospital Center, Washington, DC, USA. rkurman@jhmi.edu
PUBTYPE: Journal Article
JOURNALTITLE: Histopathology.
COUNTRY: England
TITLE: Serous borderline tumours of the ovary.
PUBDATE: 20050901
Serous borderline tumours of the ovaryIn this Expert Opinion we have invited articles from two leading groups, to discuss serous borderline tumours (serous tumours of low malignant potential) of the ovary from their own perspectives. Controversy remains over heterogeneity within this group of tumours and their relationship to ovarian cancer. Our authors discuss the histopathological classification of these tumours in relation to morphological appearances, molecular and clinical data. The significance of a micropapillary pattern is discussed, and issues related to extra-ovarian implants.

5. DOCID:29915 SCORE: 0.00322543441612116
DOCNO: 12530232
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Magnetic Resonance Imaging
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: Lawrence E Ginsberg LE
AFFILIATION: Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Box 57, 1515 Holcombe Boulevard, Houston, TX 77030, USA. lginsberg@di.mdacc.tmc.edu
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Magnetic resonance imaging clinics of North America.
COUNTRY: United States
TITLE: MR imaging of perineural tumor spread.
PUBDATE: 20020801
Perineural tumor spread (PNS) is a common and potentially devastating complication of head and neck cancer. Because perineural tumor spread may be asymptomatic, the radiologist plays a critical role in the evaluation of the head and neck cancer patient. Although PNS may be seen on CT, MR imaging is far more sensitive and is the imaging modality of choice in the evaluation of perineural tumor spread.

6. DOCID:31921 SCORE: 0.00309951516172687
DOCNO: 12797851
AUTHOR: Rodney J Baber RJ
AUTHOR: Justine L O'Hara JL
AUTHOR: Frances M Boyle FM
AFFILIATION: Department of Obstetrics and Gynaecology, University of Sydney, Sydney, NSW 2006, Australia. rbaber@mail.usyd.edu.au
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: The Medical journal of Australia.
COUNTRY: Australia
TITLE: Hormone replacement therapy: to use or not to use?
PUBDATE: 20030601
The main indication for hormone replacement therapy (HRT) is to control menopausal symptoms and improve quality of life. Ideally, withdrawal of HRT should be attempted after 4-5 years of therapy. HRT reduces fracture risk and remains appropriate therapy for osteoporosis, particularly in women with symptoms. HRT is not appropriate for primary or secondary cardioprotection. HRT leads to a small increase in breast cancer incidence, which increases with duration of therapy and age. HRT increases the risk of thromboembolism. Patient management and therapy should be reviewed annually with risk-benefit counselling.

7. DOCID:31013 SCORE: 0.00276879050583723
DOCNO: 16292460
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Drug Approval
QUALIFIER: organization & administration
QUALIFIER: trends
QUALIFIER: trends
QUALIFIER: organization & administration
QUALIFIER: organization & administration
AUTHOR: G Geiges G
AUTHOR: A Böhle A
AUTHOR: H Rexer H
AFFILIATION: Urologische Praxis, Berlin.
PUBTYPE: Journal Article
JOURNALTITLE: Der Urologe. Ausg. A.
COUNTRY: Germany
TITLE: [Study participation in urological specialty practices]
PUBDATE: 20051201
In the past, participation of practicing urologists in clinical trials has been very rare. The reasons for this have been influenced in different ways over the last 10 years, so that the situation has now changed. In this paper, the current motivation for the participation of practicing urologists in research studies is discussed. Moreover, we discuss the ways in which the Association of Urological Oncology (AUO) of the German Cancer Association promotes the participation of colleagues in AUO studies and how the AUO meets the needs of urologists in practice.

8. DOCID:30952 SCORE: 0.0027687875683106
DOCNO: 15148898
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Attitude to Health
DESCRIPTOR: Health Knowledge, Attitudes, Practice
DESCRIPTOR: Skin Neoplasms
QUALIFIER: psychology
AUTHOR: Lenore M Lamanna LM
AFFILIATION: State University of New York at Stony Brook, Stony Brook, NY, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Dermatology nursing / Dermatology Nurses' Association.
COUNTRY: United States
TITLE: College students' knowledge and attitudes about cancer and perceived risks of developing skin cancer.
PUBDATE: 20040401
Skin cancer is the most commonly occurring cancer in the United States. Primary prevention practices for skin cancer are fully documented in the literature for reducing the damaging effects of ultraviolet radiation on skin. Late adolescents, inherent to their young age and risk-taking behaviors, are more likely to sunbathe. The cancer attitudes and suntanning knowledge, attitudes, perceptions, beliefs, and behaviors among college students were examined. Gender-specific interventions for educating this age group are recommended.

9. DOCID:30742 SCORE: 0.00273380634149038
DOCNO: 14633302
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: physiopathology
QUALIFIER: blood supply
QUALIFIER: physiopathology
AUTHOR: Gelareh Zadeh G
AUTHOR: Abhijit Guha A
AFFILIATION: Arthur & Sonia Labatts Brain Tumor Center, Hospital for Sick Children's Research Institute, University of Toronto, Toronto, Ontario, Canada.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Neurosurgery.
COUNTRY: United States
TITLE: Angiogenesis in nervous system disorders.
PUBDATE: 20031201
Angiogenesis is a crucial requirement for embryonal development and new vessel formation during adult life. Various disease processes such as cancer, ischemia, vascular malformations, and inflammatory processes also depend on pathological angiogenesis. A better understanding of the complex and coordinated interactions among various angiogenic pathways involved in pathological angiogenesis is necessary to improve our therapeutic approaches to the various disease processes observed in the central nervous system. This review summarizes the current understanding of the role of principal angiogenic factors relevant to neurosurgical abnormalities.

10. DOCID:29936 SCORE: 0.00268471768578395
DOCNO: 15794772
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Penile Induration
AUTHOR: Christopher J Smith CJ
AUTHOR: Chelsea McMahon C
AUTHOR: Ridwan Shabsigh R
AFFILIATION: Department of Urology, Columbia University, New York, New York, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: BJU international.
COUNTRY: England
TITLE: Peyronie's disease: the epidemiology, aetiology and clinical evaluation of deformity.
PUBDATE: 20050401
There is a wide variety of topics covered in this section. The epidemiology, aetiology and clinical evaluation of the deformity in Peyronie's disease is described, followed by a discussion of recent advances in the biology of diabetes-associated bladder complications. Bladder cancer and its molecular prognostic factors are presented, and the section ends with an in-depth presentation of an evidence-based approach to the understanding of the pharmacological class effect in the management of prostatic diseases.

11. DOCID:29925 SCORE: 0.00268471585546559
DOCNO: 12168186
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Arthroplasty, Replacement, Hip
DESCRIPTOR: Hip Prosthesis
QUALIFIER: injuries
QUALIFIER: surgery
QUALIFIER: surgery
QUALIFIER: surgery
AUTHOR: Cyna Khalily C
AUTHOR: Victor M Ilizaliturri VM
AUTHOR: D Kevin Lester DK
AFFILIATION: Private practice, Wellington Orthopaedics and Sports Medicine, Cincinnati, Ohio 45247, USA.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of arthroplasty.
COUNTRY: United States
TITLE: Bilateral pathologic fractures of the hip and acetabulum treated with cementless total hip arthroplasty.
PUBDATE: 20020801
Pathologic fractures from metastatic cancer pose formidable challenges to the orthopaedic surgeon technically and in terms of surgical decision making with regards to patient quality of life. We present the case of a 47-year-old woman with simultaneous bilateral pathologic femoral neck and acetabulum fractures and severe pulmonary shunt, who was treated successfully with cementless femoral and acetabular implants.

12. DOCID:30751 SCORE: 0.00261220004002913
DOCNO: 12881379
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: mortality
QUALIFIER: prevention & control
QUALIFIER: methods
QUALIFIER: organization & administration
AUTHOR: P Sasieni P
AFFILIATION: Cancer Research UK Department of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventative Medicine, London, UK. peter.sasieni@cancer.org.uk
PUBTYPE: Evaluation Studies
PUBTYPE: Journal Article
JOURNALTITLE: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.
COUNTRY: England
TITLE: Evaluation of the UK breast screening programmes.
PUBDATE: 20030801
National breast screening programmes were set up in the UK in the early 1990s. Although they are quality-assured and publish process measures of performance, there is a lack of data linking the screening process to breast cancer mortality. A new analysis of trends in England and Wales suggests that the effect of screening has been to reduce mortality by 8% over 10 years in those eligible for screening in 1990.

13. DOCID:29558 SCORE: 0.00250800187172178
DOCNO: 15088455
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Health Care Reform
DESCRIPTOR: Organizational Objectives
DESCRIPTOR: Quality of Health Care
PUBTYPE: Journal Article
JOURNALTITLE: The Quality letter for healthcare leaders.
COUNTRY: United States
TITLE: Transforming healthcare: IOM panel discusses vision and reality after Crossing the Quality Chasm.
PUBDATE: 20040301
Almost 3 years ago, the Institute of Medicine (IOM) released its pivotal report, Crossing the Quality Chasm, which challenged the healthcare community to reevaluate and reinvent the way it provides care. In January, the IOM hosted an invitational summit in Washington, DC to look at whether that vision is becoming a reality across the country and in local communities. The summit focused on five priority areas: asthma, chronic heart failure, major depression, diabetes, and pain control in advanced cancer.

14. DOCID:30403 SCORE: 0.00246537085111916
DOCNO: 12901235
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: methods
AUTHOR: Jeffrey W Smith JW
AFFILIATION: Burnham Institute, 10901 N Torrey Pines Road, La Jolla, CA 92037-1005, USA. jsmith@burnham.org
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Current opinion in investigational drugs (London, England : 2000)
COUNTRY: England
TITLE: Cilengitide Merck.
PUBDATE: 20030601
Merck KGaA is developing cilengitide, the lead in a series of integrin antagonists with anti-angiogenic activities, for the potential treatment of a variety of cancer types. The National Cancer Institute is conducting clinical trials of cilengitide. In October 1999, phase II trials in non-small-cell lung cancer (as a monotherapy) and pancreatic cancer (in combination with gemcitabine) were initiated. These were ongoing in February 2002, by which time, a phase I trial and a phase I/II trial in glioblastoma were underway.